Efficacy and Safety of Conbercept in Macular Edema Secondary to Retinal Vein Occlusion

NCT01809236 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Retinal Vein Occlusion

Interventions

BIOLOGICAL: Conbercept

Sponsor

Chengdu Kanghong Biotech Co., Ltd.